Created in 2015 (United States), SYNDROS own 2 sister brands. The SYNDROS brand is owned by Insys Therapeutics, a company listed in New York. SYNDROS is part of the Divers activity sector.
Share price brand.technical-problem
Yield (Dividend per share)
(2019-2023) Stoxx Europe 600 : +36.90 % S&P 500 NY : +84.20 %